PE20091224A1 - Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion - Google Patents

Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion

Info

Publication number: PE20091224A1
Authority: PE; Peru
Prior art keywords: mixtures; weight; pharmaceutical composition; sodium; talc
Prior art date: 2007-08-06

Application number

PE2007001452A

Other languages

English (en)

Spanish (es)

Inventor

Urzua Marcos Morales

Chen Shu Chen

Apablaza Marianela Beltran

Original Assignee

Andromaco Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-06

Filing date

2007-10-25

Publication date

2009-08-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51359501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091224(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-10-25 Application filed by Andromaco Lab filed Critical Andromaco Lab

2009-08-26 Publication of PE20091224A1 publication Critical patent/PE20091224A1/es

Links

AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title abstract 2
229960001243 orlistat Drugs 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000843 powder Substances 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 7
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
229940075614 colloidal silicon dioxide Drugs 0.000 abstract 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
239000004094 surface-active agent Substances 0.000 abstract 2
239000000454 talc Substances 0.000 abstract 2
229910052623 talc Inorganic materials 0.000 abstract 2
235000012222 talc Nutrition 0.000 abstract 2
229920002261 Corn starch Polymers 0.000 abstract 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
229930195725 Mannitol Natural products 0.000 abstract 1
229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
102000019280 Pancreatic lipases Human genes 0.000 abstract 1
108050006759 Pancreatic lipases Proteins 0.000 abstract 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
229920002472 Starch Polymers 0.000 abstract 1
235000021355 Stearic acid Nutrition 0.000 abstract 1
239000006096 absorbing agent Substances 0.000 abstract 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 abstract 1
239000008116 calcium stearate Substances 0.000 abstract 1
235000013539 calcium stearate Nutrition 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000008120 corn starch Substances 0.000 abstract 1
238000010790 dilution Methods 0.000 abstract 1
239000012895 dilution Substances 0.000 abstract 1
239000007884 disintegrant Substances 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
239000008101 lactose Substances 0.000 abstract 1
239000000314 lubricant Substances 0.000 abstract 1
235000019359 magnesium stearate Nutrition 0.000 abstract 1
239000000594 mannitol Substances 0.000 abstract 1
235000010355 mannitol Nutrition 0.000 abstract 1
229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
239000008108 microcrystalline cellulose Substances 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
229940116369 pancreatic lipase Drugs 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
229940057838 polyethylene glycol 4000 Drugs 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
229940079832 sodium starch glycolate Drugs 0.000 abstract 1
239000008109 sodium starch glycolate Substances 0.000 abstract 1
229920003109 sodium starch glycolate Polymers 0.000 abstract 1
235000019698 starch Nutrition 0.000 abstract 1
239000008117 stearic acid Substances 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

PE2007001452A 2007-08-06 2007-10-25 Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion PE20091224A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CL2007002287A CL53426B (sr)	2007-08-06	2007-08-06

Publications (1)

Publication Number	Publication Date
PE20091224A1 true PE20091224A1 (es)	2009-08-26

Family

ID=51359501

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PE2007001452A PE20091224A1 (es)	2007-08-06	2007-10-25	Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion

Country Status (7)

Country	Link
CL (1)	CL53426B (sr)
CR (1)	CR10132A (sr)
DO (1)	DOP2008000021A (sr)
MX (1)	MX2008010082A (sr)
PA (1)	PA8786701A1 (sr)
PE (1)	PE20091224A1 (sr)
SV (1)	SV2009002991A (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL216542B1 (pl) *	2008-03-20	2014-04-30	Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna	Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku

2007
- 2007-08-06 CL CL2007002287A patent/CL53426B/es active
- 2007-10-25 PE PE2007001452A patent/PE20091224A1/es active IP Right Grant
2008
- 2008-04-10 DO DO2008000021A patent/DOP2008000021A/es unknown
- 2008-07-01 PA PA20088786701A patent/PA8786701A1/es unknown
- 2008-07-07 CR CR10132A patent/CR10132A/es not_active Application Discontinuation
- 2008-07-31 SV SV2008002991A patent/SV2009002991A/es unknown
- 2008-08-06 MX MX2008010082A patent/MX2008010082A/es active IP Right Grant

Also Published As

Publication number	Publication date
MX2008010082A (es)	2009-04-17
CL2007002287A1 (sr)	2007-12-14
CR10132A (es)	2008-10-28
DOP2008000021A (es)	2009-11-30
CL53426B (sr)	2016-11-28
PA8786701A1 (es)	2009-04-23
SV2009002991A (es)	2009-04-16

Similar Documents

Publication	Publication Date	Title
EA200970291A1 (ru)	2009-06-30	Фармацевтическая композиция, содержащая розувастатин кальция
GT200600194A (es)	2006-12-04	Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
MX2010004897A (es)	2010-05-19	Forma de dosificacion oralmente desintegrada.
PE20201496A1 (es)	2020-12-29	Composiciones y metodos para tratar anemia
EA029081B9 (ru)	2018-09-28	Комбинированный состав двух противовирусных соединений
PH12013500695A1 (en)	2017-08-09	Pharmaceutical compositions containing a dgat1 inhibitor
HRP20211752T1 (hr)	2022-02-18	Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
UA104869C2 (uk)	2014-03-25	Фармацевтичні композиції, що містять ліганди рецептора дофаміну
NO20085110L (no)	2009-02-06	Substituerte spirosykliske CGRP-reseptorantagonister
RU2008135718A (ru)	2010-03-20	Композиции клопидогреля бисульфата
EA200801926A1 (ru)	2009-04-28	Таблетки парацетамола с быстрым высвобождением
ATE493412T1 (de)	2011-01-15	Spirohydantoin-aryl-cgrp-rezeptorantagonisten
CR9953A (es)	2008-10-08	Diarilurea para el tratamiento de hipertension pulmonar
UA99136C2 (ru)	2012-07-25	Улучшенная фармацевтическая композиция, содержащая антагонист кальциевых каналов - лерканидипин, способ ее получения
ATE537170T1 (de)	2011-12-15	Cgrp-rezeptorantagonisten
IN2012DN02502A (sr)	2015-08-28
SG178975A1 (en)	2012-04-27	Indenone derivative and pharmaceutical composition comprising same
ATE460154T1 (de)	2010-03-15	Bioresorbierbare zusammensetzung mit kontrollierter freisetzung
CR20110209A (es)	2011-05-27	Composición farmacéutica sólida
AR061093A1 (es)	2008-08-06	Composiciones de calcio
HRP20100120T1 (hr)	2010-04-30	Formulacije s valsartanom
ES2922903T3 (es)	2022-09-21	Composición farmacéutica que comprende sales de lenvatinib
TR201101807T2 (tr)	2012-02-21	Rosuvastatin kalsiyumun farmasotik bileşimleri
RU2008139625A (ru)	2010-04-20	Композиции и способы лечения ревматоидного артрита
PE20091224A1 (es)	2009-08-26	Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion

Legal Events

Date	Code	Title	Description
2012-01-10	FG	Grant, registration